DreamCIS INC. Logo

DreamCIS INC.

A CRO providing clinical research services for pharma, biotech, and medical device industries.

223250 | KO

Overview

Corporate Details

ISIN(s):
KR7223250002
LEI:
Country:
South Korea
Address:
서울특별시 종로구 사직로 130 적선현대빌딩, 10층 10호, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DreamCIS, Inc. is a Contract Research Organization (CRO) that provides comprehensive clinical research services for the pharmaceutical, biotechnology, and medical device industries. The company's offerings include clinical development, biostatistics, data management, project management, and consulting. DreamCIS has extensive experience in managing clinical trials across a broad range of therapeutic areas, including oncology, cardiovascular diseases, endocrinology, and rare diseases. It also conducts Non-Interventional Studies (NIS) and Post-Marketing Surveillance (PMS) to support products throughout their lifecycle.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 99.0 KB
2025-08-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 8.8 KB
2025-08-14 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.5 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-06-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-09 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 15.1 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 32.0 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.8 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 2.0 MB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-20 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 445.3 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 18.5 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 215.3 KB

Automate Your Workflow. Get a real-time feed of all DreamCIS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DreamCIS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DreamCIS INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Neonode Inc. Logo
Licenses optical sensing and computer vision for HMI in automotive and consumer electronics.
United States of America
NEON
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France
ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia
NFM
NexGen Energy Ltd. Logo
Uranium exploration company developing a high-grade mine to supply global clean energy fuel.
United States of America
NXE
Nexxen International Ltd. Logo
End-to-end programmatic ad platform for advertisers, agencies, & publishers, specializing in video & CTV.
United States of America
NEXN
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France
ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden
NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan
2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan
4893
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.